City noise worsens fibromyalgia pain, new research reveals—urban sounds trigger sharper symptoms than silence or...
Discover how spinal muscular atrophy treatment has evolved with disease-modifying therapies and early intervention for...
Ractigen Therapeutics completes patient enrollment in phase 2 clinical trial for ALS treatment using siRNA...
FDA approves tau PET imaging agent Tauklarify for Alzheimer’s disease, backed by two large studies...
Multiple sclerosis trial advances as Quantum BioPharma gains FDA clearance for Lucid‑MS phase 2 study,...
Blood biomarkers are revolutionizing early Alzheimer detection, with a new P‑tau217 blood test matching PET...
Spinal muscular atrophy treatment breakthroughs extend lives, but healthcare systems struggle to adapt to new...
Discover the latest spinal muscular atrophy treatment options, including nusinersen and onasemnogene abeparvovec, for patients...
Discover the latest developments in Spinal Muscular Atrophy treatment during SMA Awareness Month, highlighting new...
Lennox-Gastaut syndrome presents complex care challenges. Learn about treatment advancements and how to plan for...